Incanthera Plc (INC) ORD GBP0.0002

Sell:7.00pBuy:7.50p0.20p (2.76%)

Prices delayed by at least 15 minutes
Sell:7.00p
Buy:7.50p
Change:0.20p (2.76%)
Prices delayed by at least 15 minutes
Sell:7.00p
Buy:7.50p
Change:0.20p (2.76%)
Prices delayed by at least 15 minutes

Company Information

About this company

Incanthera plc is a United Kingdom-based dermatology and oncology therapeutics company. The Company's is focused on developing a range of dermatological applications utilizing its unique formulation and delivery technologies to meet the unmet needs in the skincare market. Skin + CELL is the Company’s luxury skincare brand utilizing the advanced formulation and delivery expertise, to bring scientifically proven formulations to cosmetics. Skin + CELL's formulations, enriched with targeted bioactive B3 (an activated form of niacinamide) are delivered directly into the skin's cells to optimize and protect cellular health, energy and protective capabilities. Skin + CELL's luxury skincare range extends across face, body, hand, face serum and eye serum.

Key people

Timothy Mccarthy
Executive Chairman
Simon J. Ward
Chief Executive Officer, Director
Laura Brogden
Chief Financial Officer
Suzanne Brocks
Head of Communications and Company Secretary
John Michael Ge Howes
Non-Executive Independent Director
Caroline Murray
Senior Independent Non-executive Director
Click to see more

Key facts

  • EPIC
    INC
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB00BGL7YW15
  • Market cap
    £8.47m
  • Employees
    5
  • Shares in issue
    116.90m
  • Exchange
    Aquis Stock Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.